- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$26.6b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$187.85
7D
-5.2%
1Y
26.7%
BioNTech
Market Cap: US$21.9b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$91.19
7D
-10.2%
1Y
-8.3%
Illumina
Market Cap: US$18.2b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$118.94
7D
-4.6%
1Y
38.9%
Sam Chun Dang Pharm
Market Cap: ₩18.0t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩772,000.00
7D
1.0%
1Y
303.3%
Regencell Bioscience Holdings
Market Cap: US$11.5b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$23.23
7D
-0.5%
1Y
6,894.8%
Elanco Animal Health
Market Cap: US$11.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.94
7D
-1.8%
1Y
119.7%